Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
2.240
+0.020 (0.90%)
At close: Feb 21, 2025, 4:00 PM
2.230
-0.010 (-0.45%)
After-hours: Feb 21, 2025, 7:49 PM EST
Inovio Pharmaceuticals Revenue
Inovio Pharmaceuticals had revenue of $203.41K in the twelve months ending September 30, 2024, down -76.18% year-over-year. In the year 2023, Inovio Pharmaceuticals had annual revenue of $832.01K, down -91.89%.
Revenue (ttm)
$203.41K
Revenue Growth
-76.18%
P/S Ratio
279.13
Revenue / Employee
$1,667
Employees
122
Market Cap
80.86M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 832.01K | -9.43M | -91.89% |
| Dec 31, 2022 | 10.26M | 8.49M | 478.23% |
| Dec 31, 2021 | 1.77M | -5.64M | -76.05% |
| Dec 31, 2020 | 7.41M | 3.30M | 80.24% |
| Dec 31, 2019 | 4.11M | -26.37M | -86.51% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
INO News
- 9 days ago - Inovio Pharmaceuticals Inc (INO) Oppenheimer 35th Annual Healthcare Life Sciences Conference (Transcript) - Seeking Alpha
- 10 days ago - Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications - PRNewsWire
- 12 days ago - Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference - PRNewsWire
- 23 days ago - INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - PRNewsWire
- 6 weeks ago - INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments - PRNewsWire
- 6 weeks ago - Top 3 Health Care Stocks That Could Blast Off This Month - Benzinga
- 2 months ago - Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet - Benzinga
- 2 months ago - INOVIO Announces Pricing of $30 Million Public Offering - PRNewsWire